The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event‐free survival in the NOPHO ALL92 protocol

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|61|4|653-658

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.4, 2014-04, pp. : 653-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 427-433

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 53-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized therapy for childhood acute lymphoblastic leukemia

By Raetz Elizabeth A   Bhojwani Deepa   Min Dong-Joon   Carroll William L  

Personalized Medicine, Vol. 2, Iss. 4, 2005-11 ,pp. : 349-361

Future Medicine

Access to resources Recommend Favorite

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3577-3590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 572-577

John Wiley & Sons Inc

Access to resources Recommend Favorite